GARDASIL 9 HPV vaccine approved in the European Union
17 June 2015 | By Victoria White
GARDASIL 9 is approved in the EU for active immunisation against premalignant lesions and cancers affecting the cervix, vulva, vagina or anus...
List view / Grid view
News
FDA approves ZOMIG Nasal Spray migraine treatment for use in the US in paediatric patients
17 June 2015 | By Victoria White
The FDA has approved ZOMIG Nasal Spray for use in the US in paediatric patients 12 years of age and older for the treatment of migraine with or without aura...
Oncopeptides presents clinical results from Phase I/II study of melflufen and dexamethasone in patients with relapsed and relapsed refractory multiple myeloma
17 June 2015 | By Victoria White
Oncopeptides has presented results from an ongoing study of melflufen with dexamethasone in patients with relapsed and relapsed refractory multiple myeloma...
Astellas announces preliminary Phase 1/2 data for ASP2215 in patients with relapsed or refractory acute myeloid leukaemia
17 June 2015 | By Victoria White
Preliminary data from a Phase 1/2 trial on Astellas’ ASP2215 were presented at the European Haematology Association annual congress...
Teva announces positive top-line results from a study evaluating SD-809 in tardive dyskinesia
16 June 2015 | By Victoria White
Teva has announced positive top-line results from a study designed to evaluate the efficacy of SD-809 in the treatment of tardive dyskinesia...
Rotary grants US$40.3 million to eradicate polio worldwide
16 June 2015 | By Victoria White
Rotary has granted $40.3 million to support immunisation activities and research carried out by the Global Polio Eradication Initiative...
New publication describes effective reversal of Pradaxa in healthy volunteers
16 June 2015 | By Victoria White
Results from a healthy volunteer study investigating the reversal of the anticoagulant effect of Pradaxa by idarucizumab have been published...
3DPRG at The University of Nottingham has unveiled its new lab
16 June 2015 | By Victoria White
The Additive Manufacturing and 3D Printing Research Group (3DPRG) at The University of Nottingham has unveiled its new lab.
Genzyme initiates Phase 1/2 clinical trial to evaluate olipudase alfa in paediatric patients
16 June 2015 | By Victoria White
The first paediatric patient has begun treatment in Genzyme’s Phase 1/2 clinical trial focused on evaluating the investigational therapy olipudase alfa...
FDA accepts Teva’s Biological License Application for reslizumab for review
15 June 2015 | By
The US Food and Drug Administration (FDA) has accepted for review Teva’s Biologics License Application (BLA) for reslizumab...
Reducing risk from bacterial endospores in aseptic preparation supported by Cherwell
15 June 2015 | By Cherwell Laboratories
Cherwell aids additional training opportunities for cleanroom biodecontamination...
CPhI Worldwide announces the opening of the annual CPhI Pharma Awards for 2015
15 June 2015 | By Victoria White
CPhI has announced the opening of the annual CPhI Pharma Awards for 2015 – with five new categories covering the entire pharmaceutical supply chain...
Tosedostat in combination with low dose cytarabine achieves primary endpoint in Phase 2 study
15 June 2015 | By Victoria White
CTI BioPharma has announced findings from a Phase 2 trial of tosedostat in combination with low dose cytarabine in patients with acute myeloid leukaemia...
Results from analyses of REVLIMID MCL-002 (SPRINT) study presented at EHA 2015
15 June 2015 | By Victoria White
Analyses of Celgene’s MCL-002 study, comparing Revlimid with investigators' choice in MCL, were presented at the European Haematology Association congress...
How a TV programme changed patients’ use of statins
15 June 2015 | By Victoria White
More than 60,000 Australians are estimated to have reduced or discontinued their use of prescribed statins following the airing of a TV programme...
